5-position modified pyrimidines and their use
US9163056B2 · kind B2 · utility
13Cited by
42References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 1, 2013 |
| Grant date | Oct 20, 2015 |
| Priority date | — |
| Expiry date | Nov 1, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/335
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to the field of nucleic acid chemistry, specifically to 5-position modified uridines as well as phosphoramidite and triphosphate derivatives thereof. The present disclosure also relates to methods of making and using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.